Insider Trading & Ownership of Gabriele M. Cerrone

Location: New York, NY
Summary: The estimated net worth of Gabriele M. Cerrone is at least $84,885,019 dollars as of 18 Mar 2026. Gabriele M. Cerrone is the Director, 10%+ Owner of Tiziana Life Sciences Ltd and owns shares of Tiziana Life Sciences Ltd (TLSA) stock worth about $59.84M. Gabriele M. Cerrone is the Director, 10%+ Owner of OKYO Pharma Ltd and owns shares of OKYO Pharma Ltd (OKYO) stock worth about $17.89M. Gabriele M. Cerrone is the Director, 10%+ Owner of Accustem Sciences Inc. and owns shares of Accustem Sciences Inc. (ACUT) stock worth about $7.15M.
Signature: /s/ Gabriele Cerrone
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Gabriele M. Cerrone and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

Gabriele M. Cerrone has 3 issuer positions tracked on this page.
Estimated disclosed ownership value: $84,885,019.
Recent insider filing activity is available below.

Change

Largest disclosed position: Tiziana Life Sciences Ltd ($59,837,472).
Past-year value change for that position: .

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gabriele M. Cerrone

TLSA Forms 3/4/5

Tiziana Life Sciences Ltd

Relationship: Director, 10%+ Owner
Holdings value: $59,837,472
Past year net change
Change %
Report period: 18 Mar 2026

OKYO Forms 3/4/5

OKYO Pharma Ltd

Relationship: Director, 10%+ Owner
Holdings value: $17,894,907
Past year net change
Change %
Report period: 18 Mar 2026

ACUT Forms 3/4/5

Accustem Sciences Inc.

Relationship: Director, 10%+ Owner
Holdings value: $7,152,640
Past year net change: +$20,902
Change %: +0.29%
Report period: 13 Jun 2025

Insider Transactions Reported by Gabriele M. Cerrone:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.